Leading Virtual Teams in the Pharma & Biotech World

The majority of work that gets done in the pharma and biotech industry is done with teams. But what has changed in the last decade is that most of these teams are now “virtual,” with many team members geographically dispersed. Not only are these team members remotely located, but they often work in both different time zones and country cultures.

In this audio conference, our speaker, who has travelled the globe working with virtual teams, offers insights and tips for building relationships and trust, maximizing collaboration, and achieving world-class results without the benefit of face-to-face teamwork.

Leading Virtual Teams in the Pharma & Biotech World is being presented by Lynda McDermott, President, of EquiPro International and airs on Tuesday, January 26, 2010. For more details or to register, please visit our site at www.fxconferences.com

Stay in the Game: Leading Pharma and Biotech Teams in Tough Times

What do you want others to say of your leadership during these challenging times? When the going gets tough, thanks to conditions such as dropping revenues and profits, mergers and acquisitions, re-organizations or shrinking pipelines, there is an opportunity for leaders to step up and stand out. It is also a time to step back for a little self-reflection on just what are the leadership requirements for this “new normal” of organizational life.

Based on over 20 years of experience working with such companies as Pfizer, Sanofi-Aventis, Biogen Idec and Boehringer Ingelheim, in both research and commercial divisions around the world, Lynda McDermott provides attendees with “best practice” leadership learnings and tools to help you and your people “stay in the game."

Stay in the Game: Leading Pharma and Biotech Teams in Tough Times is being presented by Lynda McDermott, President, of EquiPro International and airs on Thursday, December 17, 2009. For more details or to register, please visit our site at www.fxconferences.com

Creating and Sustaining Successful Pharma & Biotech Alliance Teams

Alliances in the pharma and biotech industries are on the rise, growing over 80% over the last 10 years. The problem is that as many as 60% to 70% of these alliances underperform or even fail. Yet despite such past performance, most companies expect to continue to form strategic alliances. If alliances remain an inevitable part of corporate strategy, pharma and biotech companies must learn how to create and sustain successful alliances.

Drawing on experience working with such companies as Pfizer, Biogen Idec, Boehringer Ingelheim, and P&G Pharmaceuticals and their alliance teams, Lynda McDermott provides conference attendees with insight into the best practices and relevant tools for launching and developing successful alliance teams.

Creating and Sustaining Successful Pharma & Biotech Alliance Teams is being presented by Lynda McDermott, President, with EquiPro International and airs on Wednesday, May 27, 2009. For more details or to register, please visit our site at www.fxconferences.com

Building Bridges: A Practical Guide to Leading Global Pharma and Biotech Teams

Today, whether the task is to develop a new drug, launch a product or work on a strategic project, much of our work is done through global teams. These teams are usually cross-functional, cross-geographic, cross-cultural and span multiple time zones. They may also cross company lines through strategic alliances. They face the challenges of having to work "virtually", with a balance of high tech and high touch.

Based on Lynda's experience working with over 1,000 global teams in over 25 countries, She will provide the participants with "best practice" learnings and tools relevant to developing and leading world class global teams.

Building Bridges: A Practical Guide to Leading Global Pharma and Biotech Teams is presented by Lynda McDermott, President, of EquiPro International and airs Wednesday, November 19, 2008. For more details or to register please visit our site www.fxconferences.com